Podcast appearances and mentions of James Howard

In the second episode of our mini-series on UK Golf Club Managers, Leighton is on-site at Stratford Oaks Golf Club near Stratford-upon-Avon to chat with James Howard, General Manager. Formerly a proprietary club, Stratford Oaks is now proudly member-owned. James is leading the way in shaping the club's future with a strategic plan focused on water security, including the ambitious construction of a reservoir. This major project is being supported by a number of smaller initiatives designed to grow revenue and strengthen the club, such as the Trackman Driving Range, clubhouse improvements, golf operations, and the pro shop. With a strong background in golf but in his first GM role, James shares some great insights into what makes a modern golf club thrive. More importantly, he's not just talking the talk—he's walking the walk at Stratford Oaks. https://www.stratfordoaks.co.uk/   Connect with Us: Instagram: @golfclubtalkuk Website: Golf Club Talk UK https://www.linkedin.com/in/leighton-walker-2708b627/   A big thanks to our partner  - Toro Click here for more information   https://eddiebullockgolf.com/   Support us here: https://buymeacoffee.com/gctuk Rate & Review Please leave a 5-star review and share this episode with your golf circle!

Send us a text We follow 19-year-old Private James Howard Smith from Liberty, Utah to the second wave landing on Utah Beach during the D-Day invasion. Born in Arkansas but settled in Utah by 1934, Smith registered for the draft the day after turning 18 and was in uniform just months later. His brief but valiant service with the 90th Infantry Division's 357th Regiment ended on June 19, 1944, amid the brutal hedgerow fighting that characterized the Normandy campaign. The regiment's own journal described it as "one of the worst baptisms of fire ever undergone by an American infantry unit." Smith's remains wouldn't return home until April 1949, nearly five years after his sacrifice, when he received final military honors at Ogden City Cemetery. His story represents thousands of similar narratives that would be lost without deliberate preservation.Discover these powerful stories yourself at webercountysgreatestgeneration.com where you'll find books, podcasts, and blog posts dedicated to ensuring Weber County's wartime contributions are never forgotten. Join us next week as we cross the globe to the Pacific Theater to honor Marine PFC Neil F. Dudman, who fell during the Battle of Saipan.

May 18, 2025 - James Howard - Bible Class by Buford Church of Christ

Graduate Student Appreciation Week is an annual celebration of the contributions of graduate students across the nation. At Baylor, nearly 6,000 graduate students elevate the University through research, teaching and more. Graduate School Dean Larry Lyon and Graduate Student Association President James Howard share perspectives on graduate education at Baylor and highlight what makes graduate students distinct.

March 19, 2025 - James Howard - Christian Ethics - Toward A Health Ethic by Buford Church of Christ

Global Total Member Involvement isn't just about adding names to the church—it's about engaging every member in the mission of making disciples. Learn how preparing, planting, cultivating, harvesting, and preserving can turn your local church into a powerful soul-winning movement.

We kick it off with a short recap on Pickle Wars (only for the YouTube viewers) and announce that we are bringing Sandwiches of History to Jungle Jim's International Market Fairfield in March, and I get to be his guest star! I am SO SO stoked for this! If you haven't, check out Sandwiches of History on all social platforms. Then, I'm joined this week by musician Benjamin James Howard to talk about our favorite products that have gone by the way side, along with other products who have returned like Clearly Canadian, and Altoids Sours, which connect through his art and his new album "Vestiges."

Amy is back to tell us all about the tragedy of the lynching of Willie James Howard. Plus: Birthdays galore with Bonnie Franklin, Angela Davis, Joe Frazier and Stockard Channing. We love all of you.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/precision-medicine-in-myasthenia-gravis-crafting-personalized-treatment-strategies/32244/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/precision-medicine-in-myasthenia-gravis-crafting-personalized-treatment-strategies/32244/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/autoantibodies-in-mg-their-role-in-diagnosis-and-treatment/32239/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/understanding-disease-progression-the-shift-from-ocular-to-generalized-mg/32236/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/life-threatening-events-understanding-and-preventing-myasthenic-crisis/32237/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/autoantibodies-in-mg-their-role-in-diagnosis-and-treatment/32239/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/understanding-disease-progression-the-shift-from-ocular-to-generalized-mg/32236/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/life-threatening-events-understanding-and-preventing-myasthenic-crisis/32237/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

This week we head to Florida's Panhandle to visit with James Howard, a student and Aspiring Leader from Pensacola Christian College. James shares his journey along with some suggestions for ADs and Coaches on this edition of The Educational AD Podcast!

Writer James Howard Kuntsler on world affairs, Biden and Putin. More at: https://jameshowardkunstler.substack.com/blogSee omnystudio.com/listener for privacy information.

Golden Gate Cookie Co is Perfect for Birthday parties, corporate events, Gifts & special occasions.Cyndie Wade is the founder and owner of CUSTOM CREATIONS. Her ornaments and custom hand painted drinkware started out as gifts for friends, & now have launched into a full time career. James Howard serves as Executive Director of the Black Inventors Hall of Fame, ( www.BIHOF.org) a virtual museum devoted to immortalizing African Americans whose noteworthy inventions have improved lives.Movie Reviews and More is broadcast live Tuesdays at 5PM PT on K4HD Radio - Hollywood Talk Radio (www.k4hd.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com). Movie Reviews and More TV Show is viewed on Talk 4 TV (www.talk4tv.com).Movie Reviews and More Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

THIS WEEK! We take a look at The Last Great War Of Antiquity. The war between Rome and Persia that would last for almost thirty years. What was the casus beli for the war? How close were the Persian in winning the war, and what caused the tide of the war to change? Find out this week on "Well That Aged Well", with "Erlend Hedegart". Support this show http://supporter.acast.com/well-that-aged-well. Hosted on Acast. See acast.com/privacy for more information.

Coach Bob Lovell starts the show after a Nathaniel Finch scoreboard update, Coach talks with Nathaniel Finch about the Indiana Pacers game 3 against the New York Knicks as they finish that one out. He then talks with Mark James about the qualifications for the Indy 500 as well as the Grand Prix taking place in Indianapolis. He also talks with Howard Kellman, the voice of the Indianapolis Indians, about the Indians loss 3-0 to the Louisville Bats.  See omnystudio.com/listener for privacy information.

Our Way Black History Fact is about Willie James Howard—the young man who was lynched in a very similar way to Emmett Till.Support the showwww.civiccipher.comFollow us: @CivicCipher @iamqward @ramsesjaConsideration for today's show was provided by: Major Threads menswear www.MajorThreads.com Hip Hop Weekly Magazine www.hiphopweekly.com The Black Information Network Daily Podcast www.binnews.com

 K.T. McFarland, Former Trump Deputy National Security Advisor and the author of "Revolution: Trump, Washington and 'We The People'” Topic: Israel's goal of eradicating Hamas, Xi's trip to Vietnam Congressman Mike Kelly, Republican representing Pennsylvania's 16th District Topic: Ways and means work, Hunter Biden, "Biden fought for Brittney Griner but forgot about Fogel" (Fox News op ed) Capt. James Howard, Retired Army Captain who served in the 82nd Airborne Division Topic: Tunnel to Towers' Season of HopeSee omnystudio.com/listener for privacy information.

The Coral's James Skelly helps Andrew Male and Chris Catchpole “explore the spaces between the sun and the shadows”. To be explored, specifically: Cillian Murphy and Bela Lugosi; Phil Spector and Celine Dion; and elusive butterfly and self-proclaimed “all-out pain” Bob Lind. Oh, and new ones by Sparklehorse and our old friend Alabaster DePlume, too!TRACKLIST 1. That's Where She Belongs, by The Coral, written by James Skelly and released on Run On Records2. Elusive Butterfly, by Bob Lind, written by Bob Lind, produced by Jack Nitzsche and released on World pacific Records in 19663. Did You Know, by Alabaster De Plume, featuring Momoko Gill and MettaShiba and composed in the act of performing by Alabaster DePlume, Falle Nioke, Rozi Plain, Sarathy Korwar, Tom Skinner, Kenichi Iwasa, James Howard, Tom Herbert, Natalie Pela, Rosa Slade, Elly Condron, Luisa Gerstein, Matt Webb, Michael Chestnutt, Ursula Russell, Conrad Singh, Hannah Miller, Donna Thompson, Matthew Bourne, Momoko Gill and Ruth Goller, from the album, Come With Fierce Grace, released on International Anthem4. Evening Star Supercharger, by Sparklehorse, written by Mark Linkous and released on Anti Records5. Listening to the Higsons, by Sparklehorse, written by Mark Linkous and released on Anti Records

In today's bonus episode we're joined by Jon Brittain and James Howard. First up we're joined by Jon Brittain who has written the book, co-written the lyrics and co-directed Kathy and Stella Solve a Murder! which is returning to the Edinburgh Fringe Festival where it was a huge hit last year. The new expanded version will also tour to Bristol and Manchester. Jon Brittain is a playwright, comedy writer and director. His critically acclaimed play Rotterdam won an Olivier Award for Outstanding Achievement in an Affiliate Theatre in 2017, he went on to direct Richard Gadd's debut play Baby Reindeer, which won the same award in 2020. Jon's other work includes the cult hit shows Margaret Thatcher Queen of Soho and Margaret Thatcher Queen of Game Shows, the Fringe First Award-winning A Super Happy Story (About Feeling Super Sad), and the UK Theatre Award-winning Billionaire Boy: The Musical. He directed both of John Kearns's Fosters Award winning shows Sight Gags for Perverts and Shtick as well as shows for Tom Allen, Mat Ewins, Tom Rosenthal and others. He co-wrote a dozen episodes of Cartoon Network's The Amazing World of Gumball and was a staff writer on seasons 3 and 4 of The Crown and he is currently writing a new sitcom for Apple.Kathy and Stella Solve a Murder! runs Underbelly at the Edinburgh Fringe 2nd – 27th August before touring to Bristol Old Vic 13th – 30th September and Home Manchester 5th - 21st October. Visit www.kathyandstella.com for info and tickets. Later we speak to James Howard who plays Draco Malfoy in Harry Potter and the Cursed Child at the Palace Theatre. The production is celebrating its seventh birthday in the West End, and James has been in the show since it opened. James' theatre credits include Brave New World (Northampton Theatre Royal/Touring Consortium); Romeo and Juliet, As You Like It, Mojo, The Drunks, King Lear, Morte D'Arthur (RSC); Twelfth Night, Ivanov (Donmar Warehouse in the West End); Not About Heroes (Blackeyed Theatre Company); Antony and Cleopatra (Royal Exchange);The Duchess of Malfi (NT).  His film credits includes: Survivor, The Theory of Everything, Shoot on Sight, The Oxford Murders and Penelope whilst his television work includes Black Mirror, Dark Matters, Doctors, Emmerdale, Hollyoaks, Skins, Midsomer Murders, The Bill, Broken News, Spooks, Inspector Lynley Mysteries and Dream Team.Harry Potter and the Cursed Child is booking at the Palace Theatre until 19th May 2024. Visit www.uk.harrypottertheplay.com for info and tickets. Hosted by Andrew Tomlins. @AndrewTomlins32  Thanks for listening! Email: andrew@westendframe.co.uk Visit westendframe.co.uk for more info about our podcasts.  

Only by copying the method of Jesus can we find true success in disciple-making. Three essential steps that Jesus used to make disciples. 

See omnystudio.com/listener for privacy information.

Dr. Elie Naddaf, MD interviews Dr. James Howard, MD about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis, highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials.

Dr. Elie Naddaf, MD interviews Dr. James Howard, MD about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis, highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials.

Elie Naddaf, MD, interviews James Howard, MD, about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis (MG), highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Artifactual Journey, Philip talks with James Howard, the executive director of the Black Inventors Hall of Fame Museum. They discuss 400 years of Black inventors and their impact on American innovation. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/artifactual-journey/message

James Howard led a long career as a pilot, serving in multiple branches of the military and across several conflicts. His flying skills quickly led him to become a squadron leader and Ace. Howard won the Medal of Honor in 1944 defending American bombers from German attacks.

In this episode of "Making Waves at C-Level", Thom talks to James Howard, the founder of the Black Inventors Hall of Fame. They talk about his new documentary, "Black Inventors Got Game", race, and success.   About James Howard James Howard is a, lecturer, design historian, industrial designer/inventor of some 300 products with 18 patents. He is currently the owner/operator of Entrepreneurial U, a specialty private career school of Design Thinking. One of his courses, “Bridge” Exploring New Career Pathways, takes students through the problem solving processes: problem/necessity, solution, and execution and leads them to new career pathways and job opportunities. While teaching for more twenty years at The County College of Morris in New Jersey, Professor Howard was an owner/operator of the award-winning firm Howard Design., an industrial design practices whose clients included Coca-Cola, Colgate Palmolive, Johnson & Johnson, Nabisco, Pfizer and the CIA (Central Intelligence Agency). The New Jersey based company was one of the longest running and most profitable minority owned design firms in the country James Howard serves as Executive Director of THE BLACK INVENTORS HALL OF FAME, (www.BIHOF.org) a virtual museum), devoted to immortalizing African Americans whose noteworthy inventions have improved lives yet gone unnoticed. James also serves on the Board of Directors for the Unites States Intellectual Property Alliance, and he is presently assisting the National Inventors Hall of Fame curate their very first Black Inventors exhibit, to be open to the public in the fall of 2021. For four years James has served as a Subject matter expert on Design thinking for the Keller Innovation Center at Princeton University. He is also a visiting lecturer for the University of Texas Center for Integrated Design, James earned a Master and Bachelor of Fine Arts -Industrial Design at University of Illinois, Urbana, IL. James was recently awarded Honorary member of the National Academy Of Inventors. Contact James at JHoward@bihof.org https://bihof.org https://thomsinger.com/podcast/black-inventors-got-game Learn more about your ad choices. Visit megaphone.fm/adchoices

View our full collection of podcasts at our website: https://www.solgoodmedia.com or YouTube channel: https://www.solgood.org/subscribe

Airing this Friday at noon on KKFI 90.1 FM is the FINAL weekly episode of Kansas City Actors Radio Theatre. From the Suspense Radio series comes “Return to Dust” by George Bamber, inspired by Richard Matheson's novel “The Shrinking Man.” James Howard has made an incredible scientific discovery. While attempting to create a bio-chemical agent that shrinks cancer cells, an inadvertent lab accident has caused James to shrink to only 1-foot tall, and he's still shrinking! He is desperate to contact Dr. Bader, the only competent scientist who could reverse the process. Will Dr. Bader receive his message before James Howard returns to dust? Featuring Walter Coppage, Kendra Keller, and Keenan Ramos. Directed by Gary Heisserer, sound design by Gianna Agostina, sound supervision by Mary Robinson, and hosted by John Rensenhouse. As we return to a full season of five incredible productions (www.kcactors.org/season-18/) KCART will no longer be airing weekly on KKFI 90.1 FM. KCART will return with special episodes throughout Season 18, and you can listen to this week's episode as well as 60+ other incredible episodes, at www.kcactors.org/kcart/! -- KCART is made possible in-part by, the Richard J. Stern Foundation for the Arts, the Estelle S. and Robert A. Long Ellis Foundation, the Miller-Nichols Foundation, the Kansas City Neighborhood Tourist Development Fund, ArtsKC, the Missouri Arts Council, Theater League, and the Breidenthal-Snyder Foundation. Special thanks to Valerie and Mark Andruss.

0.00 - intro 1.30 - brief further intro 2.15 - UFO baiting 4.00- Hermetic Penetrator article on UFO baiting 9.00 - neutrinos / anti neutrinos 10.55- Are the US using anti neutrinos to lure UAP 12.15 - Drones over Swedish nuclear facilities 15.00 - 'drones' and the nuances of describing something as a drone 24.15 - Marik / Mick West debate about the gimbal video 30.00 - Sum up of Marik's arguments 34.15 - why I think skeptics/debunkers can help the overall conversation  36.00 - Is it fair to say Mick West is a liar? 39.20 - James Howard's sighting of multiple UFOs in 1954 44.40 - the moon rock damp squib 46.15 - havana syndrome in the news again 50.15 - could havana syndrome be reverse engineered ET tech? 52.00 - Speculation on how advanced other ET intelligences could possibly be